Australia markets closed

Oramed Pharmaceuticals Inc. (ORMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1800-0.0600 (-2.68%)
At close: 04:00PM EDT
2.1800 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/08/2021
31/08/2020
31/08/2019
Assets
Current assets
Cash
Cash and cash equivalents
9,055
40,464
77,245
19,296
-
Other short-term investments
152,992
115,256
16,895
20,604
-
Total cash
162,047
155,720
94,140
39,900
-
Other current assets
537
1,389
1,197
611
-
Total current assets
162,584
157,109
95,337
40,511
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,567
1,802
932
176
-
Net property, plant and equipment
1,567
1,802
932
176
-
Equity and other investments
54,926
2,700
6,692
3,928
-
Total non-current assets
57,967
4,533
32,662
4,122
-
Total assets
220,551
161,642
127,999
44,633
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
51,013
-
-
-
-
Accounts payable
551
2,175
2,606
594
-
Accrued liabilities
1,058
1,983
1,186
1,105
-
Deferred revenues
0
1,340
2,703
2,703
-
Total current liabilities
53,214
5,746
6,679
4,536
-
Non-current liabilities
Deferred tax liabilities
11
11
11
11
-
Deferred revenues
4,000
4,000
4,244
6,947
-
Other long-term liabilities
63
61
124
211
-
Total non-current liabilities
4,444
4,740
4,803
7,218
-
Total liabilities
57,658
10,486
11,482
11,754
-
Stockholders' equity
Common stock
485
476
424
284
-
Retained earnings
-157,556
-163,081
-114,852
-92,614
-
Accumulated other comprehensive income
-
-
-
-
0
Total stockholders' equity
163,821
151,812
115,773
32,879
-
Total liabilities and stockholders' equity
220,551
161,642
127,999
44,633
-